
Obe-Cel Shows Benefits in R/R B-ALL Irrespective of Morphologic Remission Status at Screening or LD
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxNVGlENDEwQnpWVWw4NERqTFlLSUZnMEVfelRUcWN5LWJWVzZIczVERlB6VjRocm9jSXpXRjhWU2RPcjlpWEl6b3pnbjc4QnRaZmk0VGZxVE5wcXJZQWN3eWdocWMwUUFpUElMZ2NMeTJNdF92VUwtSUluQ01GUUxBVHBqblFtekZ6UGN6ZkhzMFdRTU92VXc2MU9XalBzbDRjbGJMUDB2U2M2a2FEVGtGaFprNk94dHJ6QVZzYThNTlFNQlVrTmFv?oc=5" target="_blank">Obe-Cel Shows Benefits in R/R B-ALL Irrespective of Morphologic Remission Status at Screening or LD</a>&nbsp;&nbsp;<font color="#6f6f6f">OncLive</font>
